By Madison Evans - Posted at LiveAction:
Published October 17, 2025
At the end of September, the FDA approved another generic manufacturer's abortion pill — and in the outrage that followed, Health and Human Services Secretary Robert F. Kennedy, Jr. (RFK) claimed the FDA was required by law to approve it. He stated on X, “@US_FDA only approved a second generic mifepristone tablet because federal law requires approval when an application proves the generic is identical to the brand-name drug.”But is this claim accurate?
Key Takeaways:
- When the FDA approved another company's generic abortion pill, HHS Secretary Robert F. Kennedy Jr. claimed the FDA was required by law to do so.
- The FDA has failed to follow certain time-limit guidelines for drug approval, and they did so in this case as well, with the abortion drug under review for four years instead of the required 180-day limit.
- There are avenues for the denial of a drug application, including for reasons of safety and efficacy.